Article
Preliminary Findings from an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia
2024-10-29
Abstract excerpt
<h4>Background</h4> Negative symptoms are a primary driver of poor outcomes in schizophrenia spectrum disorders (SSD), but there are no FDA-approved medications or FDA-cleared therapeutics targeting negative symptoms in schizophrenia. NST-SPARK is a novel digital therapeutic targeting negative symptoms in SSD. It is a smartphone application delivering recovery-oriented cognitive therapy (CT-R), via gamified augme...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d4c4246a-3057-5f55-8d6d-4735472afd1b
- DOI
- 10.1101/2024.10.28.24315453
